80 related articles for article (PubMed ID: 12553487)
1. Venous and arterial blood lactate in HIV-infected patients.
Zala C; Harris M; Ochoa C; Tocci M; Quercia R; Mittelman G; Perez H; Cahn P; Montaner JS
Antivir Ther; 2002 Dec; 7(4):309-10. PubMed ID: 12553487
[No Abstract] [Full Text] [Related]
2. Symptomatic hyperlactatemia in an HIV-positive patient: a case report and discussion.
Antoniou T; Weisdorf T; Gough K
CMAJ; 2003 Jan; 168(2):195-8. PubMed ID: 12538549
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic hyperlactatemia associated with nucleoside analogue reverse-transcriptase inhibitor use in HIV-infected patients: a report of 24 cases in a resource-limited setting (Uganda).
Songa PM; Castelnuovo B; Mugasha EB; Ocama P; Kambugu A
Clin Infect Dis; 2007 Aug; 45(4):514-7. PubMed ID: 17638205
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA and nucleoside toxicity.
Rastegar DA
N Engl J Med; 2002 Jul; 347(3):216-8; author reply 216-8. PubMed ID: 12125710
[No Abstract] [Full Text] [Related]
5. Lactic acidosis in HIV infected children due to antiretroviral therapy.
Shah I
Indian Pediatr; 2005 Oct; 42(10):1051-2. PubMed ID: 16269849
[No Abstract] [Full Text] [Related]
6. High serum urate in HIV-infected persons: the choice of the antiretroviral drug matters.
Walker UA; Hoffmann C; Enters M; Thoden J; Behrens G; Mitzel SL
AIDS; 2006 Jul; 20(11):1556-8. PubMed ID: 16847413
[TBL] [Abstract][Full Text] [Related]
7. The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients.
Milinkovic A; Martinez E; López S; de Lazzari E; Miró O; Vidal S; Blanco JL; Garrabou G; Laguno M; Arnaiz JA; Leon A; Larrousse M; Lonca M; Mallolas J; Gatell JM
Antivir Ther; 2007; 12(3):407-15. PubMed ID: 17591031
[TBL] [Abstract][Full Text] [Related]
8. Glucose production, oxidation and disposal correlate with plasma lactate levels in HIV-infected patients on HAART.
Haugaard SB; Andersen O; Madsbad S; Iversen J; Dela F
J Infect; 2007 Jan; 54(1):89-97. PubMed ID: 16487595
[TBL] [Abstract][Full Text] [Related]
9. Hyperlactatemia in human immunodeficiency virus-infected children receiving antiretroviral treatment.
Noguera A; Fortuny C; Sanchez E; Artuch R; Vilaseca MA; Muñoz-Almagro C; Pou J; Jiménez R
Pediatr Infect Dis J; 2003 Sep; 22(9):778-82. PubMed ID: 14506367
[TBL] [Abstract][Full Text] [Related]
10. Highly active antiretroviral HIV therapy-associated fatal lactic acidosis: quantitative and qualitative mitochondrial DNA lesions with mitochondrial dysfunction in multiple organs.
Thoden J; Lebrecht D; Venhoff N; Neumann J; Müller K; Walker UA
AIDS; 2008 May; 22(9):1093-4. PubMed ID: 18520357
[No Abstract] [Full Text] [Related]
11. Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir.
Llibre JM; Domingo P; Palacios R; Santos J; Pérez-Elías MJ; Sánchez-de la Rosa R; Miralles C; Antela A; Moreno S;
AIDS; 2006 Jun; 20(10):1407-14. PubMed ID: 16791015
[TBL] [Abstract][Full Text] [Related]
12. Unrecognized near-fatal hyperlactatemia in an HIV-infected infant exposed to nucleoside reverse transcriptase inhibitors.
Koh MT
Int J Infect Dis; 2007 Jan; 11(1):85-6. PubMed ID: 16581278
[No Abstract] [Full Text] [Related]
13. Age and height predict neuropathy risk in patients with HIV prescribed stavudine.
Cherry CL; Affandi JS; Imran D; Yunihastuti E; Smyth K; Vanar S; Kamarulzaman A; Price P
Neurology; 2009 Jul; 73(4):315-20. PubMed ID: 19636052
[TBL] [Abstract][Full Text] [Related]
14. Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy.
Nelson M; Azwa A; Sokwala A; Harania RS; Stebbing J
AIDS; 2008 Jul; 22(11):1374-6. PubMed ID: 18580619
[TBL] [Abstract][Full Text] [Related]
15. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine.
Walker UA; Bäuerle J; Laguno M; Murillas J; Mauss S; Schmutz G; Setzer B; Miquel R; Gatell JM; Mallolas J
Hepatology; 2004 Feb; 39(2):311-7. PubMed ID: 14767983
[TBL] [Abstract][Full Text] [Related]
16. The case against Zerit.
Huff B
GMHC Treat Issues; 2002 Oct; 16(10):1-4. PubMed ID: 12458548
[No Abstract] [Full Text] [Related]
17. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for mortality in symptomatic hyperlactatemia among HIV-infected patients receiving antiretroviral therapy in a resource-limited setting.
Manosuthi W; Prasithsirikul W; Chumpathat N; Suntisuklappon B; Athichathanabadi C; Chimsuntorn S; Sungkanuparph S
Int J Infect Dis; 2008 Nov; 12(6):582-6. PubMed ID: 18337140
[TBL] [Abstract][Full Text] [Related]
19. Case report: nucleoside analogue-induced lactic acidosis in the third trimester of pregnancy.
Mandelbrot L; Kermarrec N; Marcollet A; Lafanechère A; Longuet P; Chosidow D; Saada M
AIDS; 2003 Jan; 17(2):272-3. PubMed ID: 12545093
[No Abstract] [Full Text] [Related]
20. Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.
Buffet M; Schwarzinger M; Amellal B; Gourlain K; Bui P; Prévot M; Deleuze J; Morini JP; Gorin I; Calvez V; Dupin N
J Clin Virol; 2005 May; 33(1):60-4. PubMed ID: 15797366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
